A pharmaceutical company selling the only drug approved to prevent preterm birth said Tuesday that it would withdraw the medicine from the market.
Covis Pharma said it told the Food and Drug Administration that it would voluntarily withdraw the medicine called Makena, which a study in 2019 showed did not work to extend pregnancies.
"While we stand by Makena's favorable benefit-risk profile, including its efficacy in women at highest risk of preterm birth, we are seeking to voluntarily withdraw the product and work with the FDA to effectuate an orderly wind-down," Raghav Chari, the company's chief innovation officer, said in a statement.
